Imatinib in chronic myeloid leukemia [3]

New England Journal of Medicine

Volumn 356, Issue 17, 2007, Pages 1780-

  Krause, Stefan W ^a   Holler, Ernst ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DISEASE FREE SURVIVAL; HUMAN; LETTER; MORTALITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 34247519156     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc063767     Document Type: Letter

References (1)

1. Druker BJ, Guilhot F, O'Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006;355:2408-17.